Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Nordion Inc. ("Nordion") (NYSE: NDZ) related to the
acquisition by Sterigenics for shareholders. Under the terms of the
definitive agreement valued at approximately $727 million, consideration
will consist of $11.75 per share in cash, which is well below at least
one analyst's estimated value of $13.00 per shre.
If you are an affected investor, and you want to learn more about the
lawsuit or join the action, contact Willie Briscoe at The Briscoe Law
Firm, PLLC, (214) 239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com,
or Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via
e-mail at firstname.lastname@example.org.
There is no cost or fee to you.
The Nordion investigation centers on whether Nordion's shareholders are
receiving adequate compensation for their shares in the proposed deal,
whether the transaction undervalues Nordion's stock, and whether
Nordion's board attempted to obtain the highest share price for all
shareholders prior to agreeing to the deal. Notably, at least one
analyst with Yahoo! Finance estimates the true inherent value of the
company could be as high as $13 per share.
Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience
in complex litigation and transactional matters.
Taylor LLP is a boutique litigation law firm that handles a variety
of complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits,
and security class actions.
[ Back To NFVZone's Homepage ]